Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

The authors reply.

Perazella MA, Dreicer R, Rosner MH.

Kidney Int. 2018 Dec;94(6):1238-1239. doi: 10.1016/j.kint.2018.08.023. No abstract available.

PMID:
30466568
2.

Treatment of Drug-Induced Acute Tubulointerstitial Nephritis: The Search for Better Evidence.

Moledina DG, Perazella MA.

Clin J Am Soc Nephrol. 2018 Nov 5. pii: CJN.12001018. doi: 10.2215/CJN.12001018. [Epub ahead of print] No abstract available.

PMID:
30397028
3.

Kidney Biopsy-Related Complications in Hospitalized Patients with Acute Kidney Disease.

Moledina DG, Luciano RL, Kukova L, Chan L, Saha A, Nadkarni G, Alfano S, Wilson FP, Perazella MA, Parikh CR.

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1633-1640. doi: 10.2215/CJN.04910418. Epub 2018 Oct 22.

PMID:
30348813
4.

Urine Sediment Examination in the Diagnosis and Management of Kidney Disease: Core Curriculum 2019.

Cavanaugh C, Perazella MA.

Am J Kidney Dis. 2018 Sep 21. pii: S0272-6386(18)30873-4. doi: 10.1053/j.ajkd.2018.07.012. [Epub ahead of print] Review.

PMID:
30249419
5.

Acute Kidney Injury in Patients With Cancer.

Perazella MA, Rosner MH.

Oncology (Williston Park). 2018 Jul 15;32(7):351-9.

6.

Cardiorenal complications of immune checkpoint inhibitors.

Sury K, Perazella MA, Shirali AC.

Nat Rev Nephrol. 2018 Sep;14(9):571-588. doi: 10.1038/s41581-018-0035-1. Review.

PMID:
30013100
7.

Opening an onconephrology clinic: recommendations and basic requirements.

Cosmai L, Porta C, Perazella MA, Launay-Vacher V, Rosner MH, Jhaveri KD, Floris M, Pani A, Teuma C, Szczylik CA, Gallieni M.

Nephrol Dial Transplant. 2018 Jul 5. doi: 10.1093/ndt/gfy188. [Epub ahead of print]

PMID:
29982771
8.

Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.

Perazella MA, Shirali AC.

J Am Soc Nephrol. 2018 Aug;29(8):2039-2052. doi: 10.1681/ASN.2018050488. Epub 2018 Jun 29.

PMID:
29959196
9.

Introduction to Nephropharmacology for the Clinician: A New CJASN Series.

Nolin TD, Perazella MA.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1083-1084. doi: 10.2215/CJN.03180318. Epub 2018 Apr 16. No abstract available.

PMID:
29661769
10.

Renal cell carcinoma for the nephrologist.

Perazella MA, Dreicer R, Rosner MH.

Kidney Int. 2018 Sep;94(3):471-483. doi: 10.1016/j.kint.2018.01.023. Epub 2018 Apr 14. Review.

PMID:
29661544
11.

Pharmacology behind Common Drug Nephrotoxicities.

Perazella MA.

Clin J Am Soc Nephrol. 2018 Apr 5. pii: CJN.00150118. doi: 10.2215/CJN.00150118. [Epub ahead of print]

PMID:
29622670
12.

Blue-green discoloration of urine and false nephrotic range proteinuria at dipstick urinalysis.

Poloni JAT, de Moraes Sassi MG, de Oliveira TF, Rotta LN, Perazella MA.

Clin Chim Acta. 2018 Jul;482:74-77. doi: 10.1016/j.cca.2018.03.036. Epub 2018 Mar 31.

PMID:
29608875
13.

Adverse Events Associated with Immune Checkpoint Blockade.

Jhaveri KD, Perazella MA.

N Engl J Med. 2018 Mar 22;378(12):1163. doi: 10.1056/NEJMc1801663. No abstract available.

PMID:
29565518
14.

Update on the nephrotoxicity of novel anticancer agents
.

Nussbaum EZ, Perazella MA.

Clin Nephrol. 2018 Mar;89(3):149-165. doi: 10.5414/CN109371. Review.

PMID:
29350175
15.

Anticancer Drug-Induced Acute Kidney Injury.

Izzedine H, Perazella MA.

Kidney Int Rep. 2017 Feb 16;2(4):504-514. doi: 10.1016/j.ekir.2017.02.008. eCollection 2017 Jul. Review.

16.

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.

Ermer T, Kopp C, Asplin JR, Granja I, Perazella MA, Reichel M, Nolin TD, Eckardt KU, Aronson PS, Finkelstein FO, Knauf F.

Kidney Int Rep. 2017 Jun 8;2(6):1050-1058. doi: 10.1016/j.ekir.2017.06.002. eCollection 2017 Nov.

17.

Atypical case of classical polyarteritis nodosa: alveolar hemorrhage and positive antineutrophil cytoplasmic antibody
.

Sitkin NA, Bernstein E, Perazella MA.

Clin Nephrol. 2018 Jan;89 (2018)(1):61-66. doi: 10.5414/CN109156.

PMID:
29162217
18.

Acute kidney injury and electrolyte disorders in the critically ill patient with cancer.

Rosner MH, Capasso G, Perazella MA.

Curr Opin Crit Care. 2017 Dec;23(6):475-483. doi: 10.1097/MCC.0000000000000450. Review.

PMID:
28953555
19.

Drug-Induced Acute Interstitial Nephritis.

Moledina DG, Perazella MA.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2046-2049. doi: 10.2215/CJN.07630717. Epub 2017 Sep 11. No abstract available.

PMID:
28893923
20.

Acute Kidney Injury in Patients with Cancer.

Rosner MH, Perazella MA.

N Engl J Med. 2017 Aug 3;377(5):500-501. doi: 10.1056/NEJMc1707248. No abstract available.

PMID:
28767352
21.

Harnessing basic and clinic tools to evaluate SGLT2 inhibitor nephrotoxicity.

Saly DL, Perazella MA.

Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F951-F954. doi: 10.1152/ajprenal.00250.2017. Epub 2017 Jun 21.

22.

The Role of PET Scanning in the Evaluation of Patients With Kidney Disease.

Krishnan N, Perazella MA.

Adv Chronic Kidney Dis. 2017 May;24(3):154-161. doi: 10.1053/j.ackd.2017.01.002. Review.

PMID:
28501078
23.

Acute Kidney Injury in Patients with Cancer.

Rosner MH, Perazella MA.

N Engl J Med. 2017 May 4;376(18):1770-1781. doi: 10.1056/NEJMra1613984. Review. No abstract available.

PMID:
28467867
24.

Diagnostic Testing in AKI: Let's Move the Field Forward.

Perazella MA.

J Hosp Med. 2017 May;12(5):380-381. doi: 10.12788/jhm.2735. No abstract available.

PMID:
28459911
25.

Kidney Injury and Repair Biomarkers in Marathon Runners.

Mansour SG, Verma G, Pata RW, Martin TG, Perazella MA, Parikh CR.

Am J Kidney Dis. 2017 Aug;70(2):252-261. doi: 10.1053/j.ajkd.2017.01.045. Epub 2017 Mar 28.

26.

Adverse kidney effects of epidermal growth factor receptor inhibitors.

Izzedine H, Perazella MA.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1089-1097. doi: 10.1093/ndt/gfw467. Review.

PMID:
28339780
27.

A Rarely Recognized Cause of Acute Kidney Injury in Rhabdomyolysis.

Tesser Poloni JA, Perazella MA.

Am J Med Sci. 2018 Sep;356(3):e27. doi: 10.1016/j.amjms.2017.03.028. Epub 2017 Mar 22. No abstract available.

PMID:
30049408
28.

Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial Disease.

Perazella MA.

Adv Chronic Kidney Dis. 2017 Mar;24(2):57-63. doi: 10.1053/j.ackd.2016.08.003. Review.

PMID:
28284380
29.

Paraprotein-Related Kidney Disease: Attack of the Killer M Proteins.

Perazella MA, Finkel KW; American Society of Nephrology Onco-Nephology Forum.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2256-2259.

30.

Checkmate: kidney injury associated with targeted cancer immunotherapy.

Perazella MA.

Kidney Int. 2016 Sep;90(3):474-6. doi: 10.1016/j.kint.2016.05.024.

PMID:
27521108
31.

The renal effects of ALK inhibitors.

Izzedine H, El-Fekih RK, Perazella MA.

Invest New Drugs. 2016 Oct;34(5):643-9. doi: 10.1007/s10637-016-0379-y. Epub 2016 Jul 29. Review.

PMID:
27468827
32.

Cancer and Mortality in Solid-Organ Transplantation: Preventable or Inevitable?

Asch WS, Perazella MA.

Am J Kidney Dis. 2016 Dec;68(6):839-842. doi: 10.1053/j.ajkd.2016.06.009. Epub 2016 Jul 9. No abstract available.

PMID:
27405594
33.

Acute kidney injury: Preventing acute kidney injury through nephrotoxin management.

Perazella MA, Wilson FP.

Nat Rev Nephrol. 2016 Sep;12(9):511-2. doi: 10.1038/nrneph.2016.95. Epub 2016 Jul 4. No abstract available.

PMID:
27374917
34.

Phosphate enemas and GFR decline: it's premature to sound the alarm.

Markowitz GS, Bomback AS, Perazella MA.

Kidney Int. 2016 Jul;90(1):13-5. doi: 10.1016/j.kint.2016.05.006.

PMID:
27312439
35.

Harmonization of Renal Function Assessment Is Needed Throughout the Whole Process of Anticancer Drug Development.

Porta C, Cosmai L, Gallieni M, Perazella MA.

J Clin Oncol. 2016 Jul 10;34(20):2429-30. doi: 10.1200/JCO.2016.67.0786. Epub 2016 May 16. No abstract available.

PMID:
27185852
36.

Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients.

Shirali AC, Perazella MA, Gettinger S.

Am J Kidney Dis. 2016 Aug;68(2):287-291. doi: 10.1053/j.ajkd.2016.02.057. Epub 2016 Apr 22.

PMID:
27113507
37.

American Society of Nephrology Quiz and Questionnaire 2015: ESRD/RRT.

Lok CE, Perazella MA, Choi MJ.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1313-20. doi: 10.2215/CJN.01280216. Epub 2016 Apr 19.

38.

Proton Pump Inhibitors and CKD.

Moledina DG, Perazella MA.

J Am Soc Nephrol. 2016 Oct;27(10):2926-2928. Epub 2016 Apr 14. No abstract available.

39.

PPIs and kidney disease: from AIN to CKD.

Moledina DG, Perazella MA.

J Nephrol. 2016 Oct;29(5):611-6. doi: 10.1007/s40620-016-0309-2. Epub 2016 Apr 12. Review.

PMID:
27072818
40.

Mistakes We Make in Dialysis: An Introduction.

Rodby RA, Perazella MA.

Semin Dial. 2016 Jul;29(4):257. doi: 10.1111/sdi.12485. Epub 2016 Apr 8. No abstract available.

PMID:
27061177
41.

The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Hu SL, Chang A, Perazella MA, Okusa MD, Jaimes EA, Weiss RH; American Society of Nephrology Onco-Nephrology Forum.

J Am Soc Nephrol. 2016 Aug;27(8):2227-37. doi: 10.1681/ASN.2015121335. Epub 2016 Mar 9. Review.

42.

Commentary.

Perazella MA.

Clin Chem. 2016 Mar;62(3):440-1. doi: 10.1373/clinchem.2015.248708. No abstract available.

43.

American Society of Nephrology Quiz and Questionnaire 2015: Transplantation.

Josephson MA, Perazella MA, Choi MJ.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1114-22. doi: 10.2215/CJN.13451215. Epub 2016 Feb 25.

44.

American Society of Nephrology Quiz and Questionnaire 2015: Glomerular Diseases.

Bomback AS, Perazella MA, Choi MJ.

Clin J Am Soc Nephrol. 2016 May 6;11(5):884-90. doi: 10.2215/CJN.12871215. Epub 2016 Feb 4. Erratum in: Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1513.

45.

American Society of Nephrology Quiz and Questionnaire 2015: Electrolytes and Acid-Base Disorders.

Rosner MH, Perazella MA, Choi MJ.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):735-44. doi: 10.2215/CJN.12801215. Epub 2016 Jan 29.

46.

Calcium oxalate crystalluria points to primary hyperoxaluria type 1.

Poloni JA, Garcia CD, Rotta LN, Perazella MA.

Kidney Int. 2016 Jan;89(1):250. doi: 10.1016/j.kint.2015.11.001. No abstract available.

PMID:
26759051
47.

Onco-nephrology: a decalogue.

Cosmai L, Porta C, Gallieni M, Perazella MA.

Nephrol Dial Transplant. 2016 Apr;31(4):515-9. doi: 10.1093/ndt/gfv320. Epub 2015 Sep 3. Review.

PMID:
26341467
48.

The role of mast cells in AIN: friend, foe, bystander, or all of the above?

Perazella MA.

Clin Nephrol. 2015 Sep;84(3):123-6. No abstract available.

49.

Nephrologists as Educators: Clarifying Roles, Seizing Opportunities.

Jhaveri KD, Perazella MA.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):176-89. doi: 10.2215/CJN.12151214. Epub 2015 Aug 14.

50.

The Authors Reply.

Perazella MA, Izzedine H.

Kidney Int. 2015 Jul;88(1):200. doi: 10.1038/ki.2015.135. No abstract available.

PMID:
26126103

Supplemental Content

Loading ...
Support Center